The pregnane X receptor: from bench to bedside

Bibliography

• Kliewer SA, Moore JT, Wade L, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998;92(1):73-82
   PubMed Web of Science ®Google Scholar
• Lehmann JM, Mckee DD, Watson MA, et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998;102(5):1016-23
   PubMed Web of Science ®Google Scholar
• Blumberg B, Sabbagh W Jr, Juguilon H, et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 1998;12(20):3195-205
   PubMed Web of Science ®Google Scholar
• Moore LB, Maglich JM, Mckee DD, et al. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol Endocrinol 2002;16(5):977-86
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Willson TM. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 2002;43(3):359-64
   PubMed Web of Science ®Google Scholar
• Kliewer SA. The nuclear pregnane X receptor regulates xenobiotic detoxification. J Nutr 2003;133(7 Suppl):S2444-7
   PubMed Web of Science ®Google Scholar
• Rosenfeld JM, Vargas R Jr, Xie W, et al. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol 2003;17(7):1268-82
   PubMed Web of Science ®Google Scholar
• Poso A, Honkakoski P. Ligand recognition by drug-activated nuclear receptors PXR and CAR: structural, site-directed mutagenesis and molecular modeling studies. Mini Rev Med Chem 2006;6(8):937-47
   PubMed Web of Science ®Google Scholar
• Honkakoski P, Sueyoshi T, Negishi M. Drug-activated nuclear receptors CAR and PXR. Ann Med 2003;35(3):172-82
   PubMed Web of Science ®Google Scholar
• Carnahan VE, Redinbo MR. Structure and function of the human nuclear xenobiotic receptor PXR. Curr Drug Metab 2005;6(4):357-67
   PubMed Web of Science ®Google Scholar
• Jacobs MN, Dickins M, Lewis DF. Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structure. J Steroid Biochem Mol Biol 2003;84(2-3):117-32
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 2002;23(5):687-702
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Ding X, Lichti K. Pregnane X receptor and natural products: beyond drug-drug interactions. Expert Opin Drug Metab Toxicol 2006;2(6):847-57
   PubMed Web of Science ®Google Scholar
• Landes N, Birringer M, Brigelius-Flohe R. Homologous metabolic and gene activating routes for vitamins E and K. Mol Aspects Med 2003;24(6):337-44
   PubMed Web of Science ®Google Scholar
• Tabb MM, Sun A, Zhou C, et al. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003;278(45):43919-27
   PubMed Web of Science ®Google Scholar
• Pacyniak EK, Cheng X, Cunningham ML, et al. The flame retardants, polybrominated diphenyl ethers, are pregnane X receptor activators. Toxicol Sci 2007;97(1):94-102
   PubMed Web of Science ®Google Scholar
• Coumoul X, Diry M, Barouki R. PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides. Biochem Pharmacol 2002;64(10):1513-9
   PubMed Web of Science ®Google Scholar
• Masuyama H, Hiramatsu Y, Kunitomi M, et al. Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate Pregnane X receptor-mediated transcription. Mol Endocrinol 2000;14(3):421-8
   PubMed Web of Science ®Google Scholar
• Goodwin B, Gauthier KC, Umetani M, et al. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci USA 2003;100(1):223-8
   PubMed Web of Science ®Google Scholar
• Mnif W, Pascussi JM, Pillon A, et al. Estrogens and antiestrogens activate hPXR. Toxicol Lett 2007;170(1):19-29
   PubMed Web of Science ®Google Scholar
• Guzelian J, Barwick JL, Hunter L, et al. Identification of genes controlled by the pregnane X receptor by microarray analysis of mRNAs from pregnenolone 16alpha-carbonitrile-treated rats. Toxicol Sci 2006;94(2):379-87
   PubMed Web of Science ®Google Scholar
• Xie W, Barwick JL, Simon CM, et al. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 2000;14(23):3014-23
   PubMed Web of Science ®Google Scholar
• Gellner K, Eiselt R, Hustert E, et al. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics 2001;11(2):111-21
   PubMedGoogle Scholar
• Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Ann Rev Pharmacol Toxicol 1999;39:1-17
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Gregory PA, Gardner-Stephen DA, et al. Regulation of UDP glucuronosyltransferase genes. Curr Drug Metab 2003;4(3):249-57
   PubMed Web of Science ®Google Scholar
• Falkner KC, Pinaire JA, Xiao GH, et al. Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors. Mol Pharmacol 2001;60(3):611-9
   PubMed Web of Science ®Google Scholar
• Geick A, Eichelbaum M, Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 2001;276(18):14581-7
   PubMed Web of Science ®Google Scholar
• Teng S, Jekerle V, Piquette-Miller M. Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab Dispos 2003;31(11):1296-9
   PubMed Web of Science ®Google Scholar
• Staudinger J, Liu Y, Madan A, et al. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos 2001;29(11):1467-72
   PubMed Web of Science ®Google Scholar
• Luo G, Cunningham M, Kim S, et al. CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos 2002;30(7):795-804
   PubMed Web of Science ®Google Scholar
• Zhu Z, Kim S, Chen T, et al. Correlation of high-throughput pregnane X receptor (PXR) transactivation and binding assays. J Biomol Screen 2004;9(6):533-40
   PubMed Web of Science ®Google Scholar
• Luo G, Guenthner T, Gan LS, et al. CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr Drug Metab 2004;5(6):483-505
   PubMed Web of Science ®Google Scholar
• Xie W, Barwick JL, Downes M, et al. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 2000;406(6794):435-9
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Goodwin B, Jones SA, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 2001;98(6):3369-74
   PubMed Web of Science ®Google Scholar
• Bertilsson G, Heidrich J, Svensson K, et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 1998;95(21):12208-13
   PubMed Web of Science ®Google Scholar
• Iyer M, Reschly EJ, Krasowski MD. Functional evolution of the pregnane X receptor. Expert Opin Drug Metab Toxicol 2006;2(3):381-97
   PubMed Web of Science ®Google Scholar
• Watkins RE, Noble SM, Redinbo MR. Structural insights into the promiscuity and function of the human pregnane X receptor. Curr Opin Drug Discov Devel 2002;5(1):150-8
   PubMed Web of Science ®Google Scholar
• Xue Y, Moore LB, Orans J, et al. Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition. Mol Endocrinol 2007;21(5):1028-38
   PubMed Web of Science ®Google Scholar
• Ma X, Shah Y, Cheung C, et al. The Pregnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A. Drug Metab Dispos 2007;35(2):194-200
   PubMed Web of Science ®Google Scholar
• Zhang H, Leculyse E, Liu L, et al. Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch Biochem Biophys 1999;368(1):14-22
   PubMed Web of Science ®Google Scholar
• Gong H, Singh SV, Singh SP, et al. Orphan nuclear receptor pregnane X receptor sensitizes oxidative stress responses in transgenic mice and cancerous cells. Mol Endocrinol 2006;20(2):279-90
   PubMed Web of Science ®Google Scholar
• Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279(15):1200-5
   PubMed Web of Science ®Google Scholar
• Niemi M, Backman JT, Fromm MF, et al. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003;42(9):819-50
   PubMed Web of Science ®Google Scholar
• Reimers D, Jezek A. The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives. Prax Pneumol 1971;25(5):255-62
   PubMedGoogle Scholar
• Backman JT, Olkkola KT, Neuvonen PJ. Rifampin drastically reduces plasma concentrations and effects of oral midazolam. Clin Pharmacol Ther 1996;59(1):7-13
   PubMed Web of Science ®Google Scholar
• Polk RE, Brophy DF, Israel DS, et al. Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males. Antimicrob Agents Chemother 2001;45(2):502-8
   PubMed Web of Science ®Google Scholar
• Grub S, Bryson H, Goggin T, et al. The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients. Eur J Clin Pharmacol 2001;57(2):115-21
   PubMed Web of Science ®Google Scholar
• Website: Herbs at a glance: St. John's Wort. Available from: http://nccam.nih.gov/health/stjohnswort/ [Last access 29 February 2008]
   Google Scholar
• Ruschitzka F, Meier PJ, Turina M, et al. Acute heart transplant rejection due to Saint John's wort. Lancet 2000;355(9203):548-9
   PubMed Web of Science ®Google Scholar
• Moore LB, Goodwin B, Jones SA, et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000;97(13):7500-2
   PubMed Web of Science ®Google Scholar
• Murakami Y, Tanaka T, Murakami H, et al. Pharmacokinetic modelling of the interaction between St John's wort and ciclosporin A. Br J Clin Pharmacol 2006;61(6):671-6
   PubMed Web of Science ®Google Scholar
• Mai I, Bauer S, Perloff ES, et al. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction. Clin Pharmacol Ther 2004;76(4):330-40
   PubMed Web of Science ®Google Scholar
• Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004;40(1):6-9
   PubMed Web of Science ®Google Scholar
• Crippin JS. Acetaminophen hepatotoxicity: potentiation by isoniazid. Am J Gastroenterol 1993;88(4):590-2
   PubMed Web of Science ®Google Scholar
• Szymanska JA, Swietlicka EA, Piotrowski JK, et al. Effects of 3-methylcholanthrene or diethyl maleate on the hepatotoxicity of acetaminophen. J Appl Toxicol 1992;12(6):415-9
   PubMed Web of Science ®Google Scholar
• Guo GL, Moffit JS, Nicol CJ, et al. Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol Sci 2004;82(2):374-80
   PubMed Web of Science ®Google Scholar
• Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004;89(11):5387-91
   PubMed Web of Science ®Google Scholar
• Coates ME. Requirements of different species for vitamins. Proc Nutr Soc 1968;27(2):143-8
   PubMed Web of Science ®Google Scholar
• Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(6 Suppl):S1678-88
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Robert A, Nguyen M, et al. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 2005;115(1):177-86
   PubMed Web of Science ®Google Scholar
• Xu Y, Hashizume T, Shuhart MC, et al. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol 2006;69(1):56-65
   PubMed Web of Science ®Google Scholar
• D'Erasmo E, Ragno A, Raejntroph N, et al. Drug-induced osteomalacia. Recenti Prog Med 1998;89(10):529-33
   PubMedGoogle Scholar
• Williams SE, Wardman AG, Taylor GA, et al. Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism. Tubercle 1985;66(1):49-54
   PubMedGoogle Scholar
• Brodie MJ, Boobis AR, Dollery CT, et al. Rifampicin and vitamin D metabolism. Clin Pharmacol Ther 1980;27(6):810-4
   PubMed Web of Science ®Google Scholar
• Igarashi M, Yogiashi Y, Mihara M, et al. Vitamin K induces osteoblast differentiation through PXR-mediated transcriptional control of the Msx2 gene. Mol Cell Biol 2007;27(22):7947-54
   PubMed Web of Science ®Google Scholar
• Sinal CJ, Tohkin M, Miyata M, et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000;102(6):731-44
   PubMed Web of Science ®Google Scholar
• Inoue Y, Yu AM, Inoue J, et al. Hepatocyte nuclear factor 4alpha is a central regulator of bile acid conjugation. J Biol Chem 2004;279(4):2480-9
   PubMed Web of Science ®Google Scholar
• Kalaany NY, Mangelsdorf DJ. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Ann Rev Physiol 2006;68:159-91
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang W, Qatanani M, et al. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J Biol Chem 2004;279(47):49517-22
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. Am J Physiol Gastrointest Liver Physiol 2005;288(1):G74-84
   PubMed Web of Science ®Google Scholar
• Hoensch HP, Balzer K, Dylewizc P, et al. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. Eur J Clin Pharmacol 1985;28(4):475-7
   PubMed Web of Science ®Google Scholar
• Galeazzi R, Lorenzini I, Orlandi F. Rifampicin-induced elevation of serum bile acids in man. Dig Dis Sci 1980;25(2):108-12
   PubMed Web of Science ®Google Scholar
• Taillan B, Chichmanian RM, Fuzibet JG, et al. Jaundice caused by rifampicin: 3 cases. Rev Med Interne 1989;10(5):409-11
   PubMed Web of Science ®Google Scholar
• Bachs L, Pares A, Elena M, et al. Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 1992;102(6):2077-80
   PubMed Web of Science ®Google Scholar
• Prince MI, Burt AD, Jones DE. Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut 2002;50(3):436-9
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhai Y, Mu Y, et al. A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J Biol Chem 2006;281(21):15013-20
   PubMed Web of Science ®Google Scholar
• Zhou J, Febbraio M, Wada T, et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 2008;134(2):556-67
   PubMed Web of Science ®Google Scholar
• Dai G, He L, Bu P, et al. Pregnane X receptor is essential for normal progression of liver regeneration. Hepatology 2008;47(4):1277-87
   PubMed Web of Science ®Google Scholar
• Mitro N, Vargas L, Romeo R, et al. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett 2007;581(9):1721-6
   PubMed Web of Science ®Google Scholar
• Morere P, Nouvet G, Stain JP, et al. Information obtained by liver biopsy in 100 tuberculous patients. Sem Hop 1975;51(31-34):2095-102
   PubMedGoogle Scholar
• Truhaut R, Claude JR, Warnet JM, et al. Liver steatogenic power of high doses of rifampicin in rats. C R Acad Sci Hebd Seances Acad Sci D 1978;286(6):493-7
   PubMedGoogle Scholar
• Piriou A, Maissiat R, Jacqueson A, et al. Ultrastructural changes in the parenchymal liver cells of rats treated with high doses of rifampicin. Br J Exp Pathol 1987;68(2):201-7
   PubMed Web of Science ®Google Scholar
• Zhai Y, Pai HV, Zhou J, et al. Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis. Mol Endocrinol 2007;21(1):138-47
   PubMed Web of Science ®Google Scholar
• Buters JT, Korzekwa KR, Kunze KL, et al. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metab Dispos 1994;22(5):688-92
   PubMed Web of Science ®Google Scholar
• Fayer JL, Petullo DM, Ring BJ, et al. A novel testosterone 6 beta-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitro. J Pharmacol Toxicol Methods 2001;46(2):117-23
   PubMed Web of Science ®Google Scholar
• Konishi H, Tanaka K, Minouchi T, et al. Urinary 6beta-hydroxycortisol/17-hydroxycorticosteroids ratio as a measure of hepatic CYP3A4 capacity after enzyme induction. Ann Clin Biochem 2004;41(Pt 4):335-7
   PubMed Web of Science ®Google Scholar
• Niwa T, Yabusaki Y, Honma K, et al. Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica 1998;28(6):539-47
   PubMed Web of Science ®Google Scholar
• Lee AJ, Kosh JW, Conney AH, et al. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. J Pharmacol Exp Ther 2001;298(2):420-32
   PubMed Web of Science ®Google Scholar
• Badawi AF, Cavalieri EL, Rogan EG. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism 2001;50(9):1001-3
   PubMed Web of Science ®Google Scholar
• Yu AM, Fukamachi K, Krausz KW, et al. Potential role for human cytochrome P450 3A4 in estradiol homeostasis. Endocrinology 2005;146(7):2911-9
   PubMed Web of Science ®Google Scholar
• Website: Safety information of rifampicin from intergovernmental organizations, International Program on Chemical Safety. Available from: http://www.inchem.org/documents/pims/pharm/rifam.htm [Last access 29 February 2008]
   Google Scholar
• Dring MM, Goulding CA, Trimble VI, et al. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 2006;130(2):341-8
   PubMed Web of Science ®Google Scholar
• Langmann T, Moehle C, Mauerer R, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004;127(1):26-40
   PubMed Web of Science ®Google Scholar
• Martinez A, Marquez A, Mendoza J, et al. Role of the PXR gene locus in inflammatory bowel diseases. Inflamm Bowel Dis 2007;13(12):1484-7
   PubMed Web of Science ®Google Scholar
• Shah YM, Ma X, Morimura K, et al. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am J Physiol Gastrointest Liver Physiol 2007;292(4):G1114-22
   PubMed Web of Science ®Google Scholar
• Chen C, Shah YM, Morimura K, et al. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab 2008;7(2):135-47
   PubMed Web of Science ®Google Scholar
• Maier A, Zimmermann C, Beglinger C, et al. Effects of budesonide on P-glycoprotein expression in intestinal cell lines. Br J Pharmacol 2007;150(3):361-8
   PubMed Web of Science ®Google Scholar
• Laustsen G, Wimmett L. 2004 drug approval highlights: FDA update. Nurse Pract 2005;30(2):14-29
   PubMedGoogle Scholar
• Shafran I, Johnson LK. An open-label evaluation of rifaximin in the treatment of active Crohn's disease. Curr Med Res Opin 2005;21(8):1165-9
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Morselli C, et al. Management of inflammatory bowel disease: does rifaximin offer any promise? Chemotherapy 2005;51(Suppl 1):96-102
   PubMed Web of Science ®Google Scholar
• Guslandi M, Petrone MC, Testoni PA. Rifaximin for active ulcerative colitis. Inflamm Bowel Dis 2006;12(4):335
   PubMed Web of Science ®Google Scholar
• Ma X, Shah YM, Guo GL, et al. Rifaximin is a gut-specific human pregnane X receptor activator. J Pharmacol Exp Ther 2007;322(1):391-8
   PubMed Web of Science ®Google Scholar
• Harmsen S, Meijerman I, Beijnen JH, et al. The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology. Cancer Treat Rev 2007;33(4):369-80
   PubMed Web of Science ®Google Scholar
• Chen Y, Tang Y, Wang MT, et al. Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res 2007;67(21):10361-7
   PubMed Web of Science ®Google Scholar
• Dotzlaw H, Leygue E, Watson P, et al. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res 1999;5(8):2103-7
   PubMed Web of Science ®Google Scholar
• Masuyama H, Hiramatsu Y, Kodama J, et al. Expression and potential roles of pregnane X receptor in endometrial cancer. J Clin Endocrinol Metab 2003;88(9):4446-54
   PubMed Web of Science ®Google Scholar
• Pfrunder A, Gutmann H, Beglinger C, et al. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 2003;55(1):59-66
   PubMed Web of Science ®Google Scholar
• Miki Y, Suzuki T, Kitada K, et al. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res 2006;66(1):535-42
   PubMed Web of Science ®Google Scholar
• Zhou J, Liu M, Zhai Y, et al. The antiapoptotic role of pregnane x receptor in human colon cancer cells. Mol Endocrinol 2008;22(4):868-80
   PubMed Web of Science ®Google Scholar
• Marek CJ, Tucker SJ, Konstantinou DK, et al. Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem J 2005;387(Pt 3):601-8
   PubMed Web of Science ®Google Scholar
• Haughton EL, Tucker SJ, Marek CJ, et al. Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. Gastroenterology 2006;131(1):194-209
   PubMed Web of Science ®Google Scholar
• Gong H, Singh SV, Singh SP, et al. Orphan nuclear receptor pregnane X receptor sensitizes oxidative stress responses in transgenic mice and cancerous cells. Mol Endocrinol 2006;20(2):279-90
   PubMed Web of Science ®Google Scholar